TreeHouse Foods (THS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Q4 2024 adjusted net sales reached $911.4 million and adjusted EBITDA was $118.3 million, both in line with expectations, with nearly 4% growth in volume and mix despite supply chain disruptions from a frozen griddle product recall.
Fiscal year 2024 adjusted net sales totaled $3.38 billion and adjusted EBITDA was $337 million, reflecting flat volume and mix amid ongoing supply chain challenges.
The acquisition of Harris Tea in January 2025 strengthens competitive positioning in private label tea and is expected to be accretive to net sales and adjusted EBITDA.
Private brand unit sales decelerated sharply in Q4 due to macroeconomic pressures, with similar trends expected in early 2025.
Executed supply chain and margin management initiatives, driving profitability despite macro challenges.
Financial highlights
Q4 2024 adjusted net sales increased 0.2% year-over-year to $911.4 million; adjusted EBITDA rose 9.1% to $118.3 million.
Adjusted EBITDA margin improved to 13% in Q4, supported by procurement savings and expense management.
FY 2024 adjusted net sales were $3.38 billion and adjusted EBITDA was $337 million, both within guidance.
Free cash flow for FY 2024 was $126.1 million, up from $16.5 million in 2023.
Operations and supply chain delivered a $29 million year-over-year benefit in Q4, with $60 million in gross savings achieved in 2024.
Outlook and guidance
FY 2025 adjusted net sales guidance: $3.34 billion to $3.40 billion, flat to +1% growth; adjusted EBITDA: $345 million to $375 million, with free cash flow of at least $130 million.
Q1 2025 adjusted net sales expected at $785 million to $800 million, down ~3.5% at midpoint; adjusted EBITDA $38 million to $46 million.
Net interest expense for 2025 is projected at $80–$90 million, and capital expenditures at approximately $125 million.
Latest events from TreeHouse Foods
- Q2 sales and EBITDA beat guidance, but net loss driven by impairment; H2 growth expected.THS
Q2 20242 Feb 2026 - Merger and related proposals approved, paving way for new ownership structure.THS
EGM 20262 Feb 2026 - Private label growth, cost savings, and a strong pipeline set the stage for margin expansion in 2024-25.THS
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Operational improvements and private label focus drive growth and stronger financial outlook.THS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Stockholders will vote on a merger with Investindustrial, offering $22.50 per share plus a CVR.THS
Proxy Filing20 Jan 2026 - Product recall and weak demand cut sales, but margin gains drove 14% EBITDA growth.THS
Q3 202414 Jan 2026 - Operational focus and portfolio optimization support stable growth amid a challenging market.THS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Shareholders to vote on a cash-and-CVR merger, with board and key investors supporting approval.THS
Proxy Filing29 Dec 2025 - Shareholders to vote on a $22.50-per-share cash merger and CVR, with board unanimous support.THS
Proxy Filing17 Dec 2025